Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 10 IN PLASTIC CONTAINER versus OSMITROL 10 IN WATER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 10 IN PLASTIC CONTAINER versus OSMITROL 10 IN WATER.
MANNITOL 10% IN PLASTIC CONTAINER vs OSMITROL 10% IN WATER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mannitol is an osmotic diuretic that increases plasma osmolarity, drawing water from tissues into the bloodstream and enhancing water excretion by the kidneys. It also reduces intracranial pressure by creating an osmotic gradient across the blood-brain barrier.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into extracellular fluid and increasing renal blood flow, thereby enhancing water excretion.
Adults: 50-100 g intravenously over 30-60 minutes, typically as a 15-25% solution. For reduction of intracranial pressure, 1.5-2 g/kg as a 20% solution IV over 30-60 minutes. For promotion of diuresis, 50-100 g as a 5-25% solution IV.
0.25-2 g/kg intravenously over 30-60 minutes, repeated every 6-12 hours as needed. Maximum dose: 2 g/kg per dose or 200 g daily.
None Documented
None Documented
Terminal elimination half-life is 0.25–1.5 hours; prolonged in renal impairment (up to 36 hours).
Terminal elimination half-life is approximately 0.25–1.5 hours in patients with normal renal function, prolonged in renal impairment.
Renal: >90% as unchanged drug; minimal biliary or fecal excretion.
Renal: >90% excreted unchanged by glomerular filtration with minimal tubular reabsorption. Negligible biliary/fecal elimination.
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic